Details for Patent: 9,918,970
✉ Email this page to a colleague
Which drugs does patent 9,918,970 protect, and when does it expire?
Patent 9,918,970 protects VESICARE LS and is included in one NDA.
This patent has twenty-three patent family members in twenty-one countries.
Summary for Patent: 9,918,970
Title: | Pharmaceutical composition comprising solifenacin |
Abstract: | Disclosed is a pharmaceutical composition comprising a complex between solifenacin or a pharmaceutically acceptable salt thereof and an ion exchange resin, and an acrylic based polymer. |
Inventor(s): | Yoshioka; Tatsunobu (Tokyo, JP), Murai; Makoto (Tokyo, JP), Tasaki; Hiroaki (Tokyo, JP) |
Assignee: | Astellas Pharma Inc. (Tokyo, JP) |
Application Number: | 13/110,295 |
Patent Claim Types: see list of patent claims | Composition; Formulation; Dosage form; | More… ↓ |
Drugs Protected by US Patent 9,918,970
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astellas | VESICARE LS | solifenacin succinate | SUSPENSION;ORAL | 209529-001 | May 26, 2020 | RX | Yes | Yes | 9,918,970 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,918,970
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2011255951 | ⤷ Subscribe | |||
Brazil | 112012029461 | ⤷ Subscribe | |||
Canada | 2799942 | ⤷ Subscribe | |||
China | 102905706 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |